alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

DALLAS DIVISION

MICHAEL D. RODGERS, SR., )

Plaintiff, )

vs. ) No. 3:05-CV-1825-N

) ECF

DARIUS HICKMAN, )

Defendant. )

ORDER ACCEPTING FINDINGS AND RECOMMENDATION

OF THE UNITED STATES MAGISTRATE JUDGE

After reviewing all relevant matters of record in this case, including the Findings, Conclusions, and Recommendation of the United States Magistrate Judge and any objections thereto, in

accordance with 28 U.S.C. § 636(b)(1), the undersigned District Judge is of the opinion that the

Findings and Conclusions of the Magistrate Judge are correct and they are accepted as the Findings

and Conclusions of the Court.

For the reasons stated in the Findings, Conclusions, and Recommendation of the United

States Magistrate Judge, the Court DENIES plaintiff’s motions for service (doc. 12) and for leave

to proceed in forma pauperis (doc. 14). By separate judgment, the Court formally dismisses this action

as frivolous, and by separate order, sanctions plaintiff as recommended by the United States

Magistrate Judge. 

SIGNED July 21, 2006.

 

 DAVID C. GODBEY

 UNITED STATES DISTRICT JUDGE 

 

 Case 3:05-cv-01825-N Document 19 Filed 07/21/06 Page 1 of 1 PageID 128
Merita FEJZULLAHU v. Roberto REYES III

2160737

Court of Civil Appeals of Alabama.

January 12, 2018 Reh. denied March 9, 2018

Affirmed.
EX-4.9



 Exhibit 4.9 

Mr Marc Voigt 
 Managing Director and Chief Executive Officer

 Prima BioMed Limited 
 08 September 2016 

Dear Marc, 
 Second Variation to Executive Employment
Agreement dated 1 August 2014 as varied on 1 June 2015 (“Agreement”) 
 Further to our recent discussions, Prima BioMed Limited
(“Prima”) agrees to vary your Agreement as set out in the attached Schedule. 
 This second variation is effective from 08 September
2016. Your new Remuneration will start being paid to you from next year (2017) on. 
 All other terms and conditions of your Agreement remain the same.

 Please indicate your acceptance of this second variation by signing (in duplicate) this letter and returning one executed copy to me. 

Prima looks forward to your ongoing assistance. 
 Yours
faithfully 
 /s/ Lucy Turnbull 
 Lucy Turnbull AO 

Chairman 
 Prima BioMed Ltd 

 

	
	I accept the variation to the Agreement
	
	 /s/ Marc Voigt

	Marc Voigt








 Schedule 

Agreed amendments to Agreement 
  

			
	 Clause
	  	 Agreed Amendment

		
	Para 2,
clause 2	  	Replace “3 years” with “6 years”
		
	Para 3,
 clause 2
	  	 Replace the whole wording of clause 2 with effect as from 1 January 2017 by the following wording:

 
 “As of 1 January 2017, Mr. Voigt shall receive by Prima Biomed GmbH in
fulfilment of the payment obligation of Prima Biomed GmbH under the employment contract as managing director of Prima Biomed GmbH between Mr. Voigt and Prima Biomed GmbH the following salary:

 
 An annual gross salary of € 215,000.00 (the “Definite Salary”)
plus an additional contingent gross salary increase of € 35,000.00 per annum (the “Increase Amount”). However, the Increase Amount is contingent upon Mr. Voigt achieving a certain one time performance milestone as resolved
by the shareholder of Prima Biomed GmbH (i.e. Prima BioMed Ltd.). The Increase Amount will be owed by Prima Biomed GmbH in full for the first time for such year, in which such performance milestone is achieved. The Definite Salary is payable by
Prima Biomed GmbH in twelve even monthly instalments at the end of each month. In the year of the achievement of the performance milestone, a pro rata portion (months lapsed in such year, including month of milestone achievement / 12) of the
Increase Amount will be due for payment at the end of the month in which the milestone was achieved; thereafter, in the remaining months of such year and in the following years of the term, the Increase Amount is payable in equal monthly instalments
(Increase Amount / 12) together with the Definite Salary. Prima Biomed GmbH may further pay Mr. Voigt a discretionary cash bonus dependent on his performance.”



  
 -2-
STATE of Louisiana v. Damon BROUSSARD

18-678

Court of Appeal of Louisiana, Third Circuit.

March 13, 2019

Keith A. Stutes, District Attorney, Roger P. Hamilton, Jr., Assistant District Attorney, Fifteenth Judicial District, P.O. Box 288, Crowley, LA 70527, Phone (337) 783-8831, COUNSEL FOR APPELLANT: State of Louisiana.

J. Kevin Stockstill, 300 Stewart Street, Lafayette, LA 70501, Phone (337) 262-0203, COUNSEL FOR DEFENDANT/APPELLEE: Damon Broussard.

Court composed of Ulysses Gene Thibodeaux, Chief Judge, Shannon J. Gremillion, and Van H. Kyzar, Judges.

KYZAR, Judge.

The State of Louisiana appeals from a trial court judgment granting a motion to quash a bill of indictment charging the defendant, Damon Broussard, with one count of molestation of a juvenile. The defendant was indicted by a grand jury with one count of molestation of a juvenile, in violation of La.R.S. 14:81.2. The indictment was filed in the trial court on February 19, 2014, under trial court docket number 81972. He was also indicted by a grand jury on one count of indecent behavior with a juvenile, in violation of La.R.S. 14:81, and one count of molestation of a *1094juvenile, in violation of La.R.S. 14:81.2, under trial court docket number 81971. The defendant was prosecuted simultaneously with common pleadings and hearings, although the cases were not officially consolidated or joined. The same motion to quash was filed and granted by the trial court under both docket numbers. The appeal of trial court docket number 81971 is the subject of a separate appeal with this court in *State of Louisiana v. Damon Broussard* , 18-677. The issues as to each appeal are identical.

For the reasons set forth in *State of Louisiana v. Damon Broussard* , 18-677 (La.App. 3 Cir. 3/13/19), 269 So.3d 1094, we reverse the decision of the trial court and remand for proceedings consistent herewith.

**REVERSED AND REMANDED.**
Donald GOINS, Petitioner, v. STATE of Florida, Respondent.

No. 1D19-0427

District Court of Appeal of Florida, First District.

May 8, 2019

FLORIDA DECISIONS WITHOUT PUBLISHED OPINIONS

Denied.
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connectionwith the Quarterly Report on Form 10-Q of The Wornick Company (the “Company”)for the thirteen week period ended July 2, 2005 as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), I,Michael M. Thompson, President and Chief Executive Officer of the Company,certify to my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of The Sarbanes-Oxley Act of 2002, that:

 

1.                                       TheReport fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

2.                                       Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 

Date:  August 16, 2005

 

 
|   | By:    | /s/ Michael  M. Thompson               |   |
|--------|--------|----------------------------------------|--------|
|   |   | Michael M.  Thompson                   |
|   |   | President  and Chief Executive Officer |

 

 

A signed original of this written statement,or other document authenticating, acknowledging, or otherwise adopting thesignature that appears in typed form within the electronic version of thiswritten statement, has been provided to the Company and will be retained by theCompany and furnished to the Securities and Exchange Commission or its staffupon request.

 

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the National Advisory Council for Human Genome Research, February 10, 2025, 9 a.m. to February 11, 2025, 5 p.m., National Institutes of Health, Capital Gateway Building, 6700B Rockledge Drive, Room 1100, Bethesda, MD 20892 which was published in the                     **Federal Register**                     on January 10, 2025, 90 FR 2710.                

Amendment to change the start time of the open session from 10 a.m. to 11:30 a.m. The meeting is partially closed to the public.

Dated: January 14, 2025.

David W. Freeman, 

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2025-01327 Filed 1-17-25; 8:45 am]

BILLING CODE 4140-01-P
FEDERAL COMMUNICATIONS COMMISSION ANNUAL APPROPRIATIONS SUMMARY

The Federal Communications Commission’s (FCC) funding is appropriated to the FCC by Congress and 

signed into law by the President through the annual appropriations process. Consolidated Appropriations 

Act, 2023 (Public Law No. 117-328) appropriated funding to the FCC through September 30, 2023 for 

Fiscal Year (FY) 2023. The actual pertinent text of the FCC’s FY 2023 funding language is contained 

below.

Federal Communications Commission FY 2023 Appropriations

“For necessary expenses of the Federal Communications Commission, as authorized by law, including 

uniforms and allowances therefor, as authorized by 5 U.S.C. 5901–5902; not to exceed $4,000 for official 

reception and representation expenses; purchase and hire of motor vehicles; special counsel fees; and 

services as authorized by 5 U.S.C. 3109, $390,192,000, to remain available until expended: Provided,

That $390,192,000 of offsetting collections shall be assessed and collected pursuant to section 9 of title I

of the Communications Act of 1934, shall be retained and used for necessary expenses and shall remain 

available until expended: Provided further, That the sum herein appropriated shall be reduced as such 

offsetting collections are received during fiscal year 2023 so as to result in a final fiscal year 2023 

appropriation estimated at $0: Provided further, That, notwithstanding 47 U.S.C. 309(j)(8)(B), proceeds 

from the use of a competitive bidding system that may be retained and made available for obligation shall 

not exceed $132,231,000 for fiscal year 2023: Provided further, That, of the amount appropriated under 

this heading, not less than $12,131,000 shall be for the salaries and expenses of the Office of Inspector 

General.”

Source: Division E - Financial Services and General Government Appropriations Act, 2023, 

Title V - Independent Agencies, Federal Communications Commission, Salaries and Expenses, of the 

Consolidated Appropriations Act, 2023 (Public Law No. 117-328), available at www.congress.gov and 

www.gpo.gov/fdsys/.
Daniel Richard GARRICK v. Sekou TOURE and Fanta Fofana

2160906

Court of Civil Appeals of Alabama.

March 9, 2018

Affirmed.
Ricky JACKSON, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-1891

District Court of Appeal of Florida, Third District.

Opinion filed March 6, 2019

**FLORIDA DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<PAGE>


                                                                 EXHIBIT 10.11


                     CONFIRMATION OF GUARANTY AND AGREEMENT

         Reference is made to that certain Guaranty (the "Guaranty") by the
undersigned of all obligations of The J. Jill Group, Inc. (the "Borrower")
executed on June 24, 2001 to Citizens Bank of Massachusetts ("Citizens"),
individually and as Agent for the benefit of, and on behalf of, all Lenders, as
such term is defined in that certain Fifth Amended and Restated Loan Agreement
among Borrower, Citizens, HSBC Bank USA, and Banknorth, N.A. dated as of June
29, 2001, as amended as of August 28, 2001, July 25, 2002, June 26, 2003, and as
the same may hereafter be amended (collectively, the "Loan Agreement"). The
undersigned hereby confirms to Citizens individually and as Agent that (i) the
Guaranty is valid, binding and enforceable against the undersigned and the
undersigned's successors and assigns in accordance with its terms and (ii)
without limiting the definition of "Obligations" thereunder, the undersigned
remains and is liable to Citizens individually and as Agent for all
"Obligations" as defined in the Guaranty.

         Reference is also made to the Loan Agreement. The undersigned hereby
confirms that any representation, warranty or covenant in said Loan Agreement
made to Citizens individually and as Agent for the benefit of, and on behalf of,
all Lenders as aforesaid by the Borrower regarding the undersigned including
without limitation, any representation about the undersigned or any covenant
that Borrower will cause the undersigned to perform or to refrain from
performing any act shall be deemed to be a direct representation, warranty or
covenant to Citizens individually and as Agent for the benefit of, and on behalf
of, all Lenders from the undersigned, and said Citizens individually and as
Agent for the benefit of, and on behalf of, all Lenders may rely upon the same
as if such representation, warranty or covenant had been made

<PAGE>

directly to Citizens individually and as Agent for the benefit of, and on behalf
of, all Lenders from the undersigned.

         Executed as an instrument under sale this 26 day of June, 2003.

                                    QT SERVICES GROUP, INC.

                                    By: /s/ Gordon R. Cooke
                                        --------------------

                                    Name: Gordon R. Cooke
                                          ---------------

                                    Title: President of QT Services Group, Inc.
                                           ------------------------------------
Case 3:05-cv-02034-M Document 9 Filed 04/11/06 Page 1 of 1 PageID 136
Case 3:05-cv-02503-G Document 10 Filed 03/20/06 Page 1 of 5 PageID 42
 

 Case 3:05-cv-02503-G Document 10 Filed 03/20/06 Page 2 of 5 PageID 43
 

 Case 3:05-cv-02503-G Document 10 Filed 03/20/06 Page 3 of 5 PageID 44
 

 Case 3:05-cv-02503-G Document 10 Filed 03/20/06 Page 4 of 5 PageID 45
 

 Case 3:05-cv-02503-G Document 10 Filed 03/20/06 Page 5 of 5 PageID 46
COWIN & CO. v. Jerry David MCCLUER

2170371

Court of Civil Appeals of Alabama.

March 6, 2018

Dismissed.
<PAGE>

                                                                EXHIBIT 10.15

                            GARDNER DENVER, INC.
               EXECUTIVE RETIREMENT PLANNING PROGRAM SERVICES


         On May 5, 2003, the Management Development Compensation Committee
of the Gardner Denver, Inc. Board of Directors approved the following tax
retirement planning program services for executive officers of Gardner
Denver, Inc.

o  Within 12 months of retirement

o  Data Collection

o  Familiarization of company plans specifically applicable to retiree

o  Determination of most tax efficient manner to draw down both
   qualified and non-qualified company and non-company plans

o  Determine adequacy of retirement cash flow including recommendations for
   maximizing same

o  Assistance with determining proper elections with respect to any company
   benefit plan at retirement

o  Stock option planning

o  Fees $8,500 - $15,000 based on today's billing rates
# C_2016106EN.01004501.xml

| 21.3.2016 | EN | Official Journal of the European Union | C 106/45 |
| --- | --- | --- | --- |

21.3.2016

EN

Official Journal of the European Union

C 106/45

---

Action brought on 1 February 2016 — Azanta v OHIM — Novartis (NIMORAL)

(Case T-49/16)

(2016/C 106/53)

Language in which the application was lodged: English

Parties

Parties

Applicant: Azanta A/S (Hellerup, Denmark) (represented by: M. Hoffgaard Rasmussen, lawyer)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Defendant:

Other party to the proceedings before the Board of Appeal: Novartis AG (Basel, Switzerland)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before OHIM

Details of the proceedings before OHIM

Applicant of the trade mark at issue: Applicant

Applicant of the trade mark at issue:

Trade mark at issue: Community word mark ‘NIMORAL’ — Application for registration No 12 204 079

Trade mark at issue:

Procedure before OHIM: Opposition proceedings

Procedure before OHIM

Contested decision: Decision of the Fourth Board of Appeal of OHIM of 1 December 2015 in Case R 634/2015-4

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | allow the registration of the contested trademark. |
| --- | --- |

—

allow the registration of the contested trademark.

Plea in law

Plea in law

| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation No 207/2009.

---
Case 5:17-cv-00017-EJD Document 12 Filed 01/04/17 Page 1 of 3
Case 5:17-cv-00017-EJD Document 12 Filed 01/04/17 Page 2 of 3
Case 5:17-cv-00017-EJD Document 12 Filed 01/04/17 Page 3 of 3
Exhibit
10.1

Compensation Arrangements

Non-Employee
Members of Board of Managers

On March 9, 2005, the Board of
Managers of Allied Security Holdings LLC (the
"Company") adopted a compensation arrangement
for the independent members of the Board of Managers pursuant to which
such independent members would receive compensation for 2005 Board
membership of $50,000 and $1,000 for each Board meeting attended. The
Audit Committee Chairperson would also receive $10,000 and each other
committee chairperson would receive $5,000 for their service as
chairpersons, and each committee member would receive $1,000 for each
committee meeting attended.

Senior Management

Effective May 6, 2005, the Company caused to be increased base
salaries for fiscal year 2005 payable to its Chief Financial Officer,
William A. Torzolini, and its Executive Vice President, Mark P.
Desrosiers, in each case as part of annual salary increases. Mr.
Torzolini's salary increased from $245,000 per annum to $290,000
per annum, and Mr. Desrosiers' base salary increased from
$215,000 per annum to $235,000 per annum.



---
Exhibit 31.1

CERTIFICATIONS

I, Dennis G. Dracup, certify that:

1. I have reviewed this Form 10-Q of Language Line, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other
financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most
recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting,
to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent function):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial reporting.



|                      |  |                                                      
|--------------------- |  | -----------------------------------------------------
|Date: August 14, 2006
|                      | 
|By:                   |  | /s/ Dennis G. Dracup                                 
|                      |  | Dennis G. Dracup Chief Executive Officer and Director
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Language Line Holdings, Inc. (the Company) for the
quarter ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Dennis G. Dracup, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(i) | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------



|(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Language Line Holdings, Inc.
|---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                                    
|------------------------------------
|Date: May 8, 2009                   
|                                    
|/s/ Dennis G. Dracup                
|Dennis G. Dracup                    
|Chief Executive Officer and Director
|(Principal Executive Officer)       

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being
filed as part of this Report.